Get In Touch With Us
Medexus Pharmaceuticals Inc. endeavors to share all the information that our investors require in order to make informed investment decisions. For questions regarding our business operations, partnerships, our product pipeline/portfolio, or for general inquiries, please reach out us using the form provided.
Medexus Pharmaceuticals, Inc.
1 Place du Commerce
Suite 225
Verdun, QC H3E 1A2
Canada
Ken d’Entremont
Chief Executive Officer and Director
ken.dentremont@medexus.com
905-676-0800
Roland Boivin
Chief Financial Officer
roland.boivin@medexus.com
514-762-2626 ext. 202
Investor Relations (US)
Crescendo Communications, LLC
David Waldman / Natalya Rudman
mdp@crescendo-ir.com
212-671-1020
Investor Relations (Canada)
Direct Financial Strategies and Communication Inc.
Frank Candido
frank.candido@medexus.com
514-969-5530
USA: For adverse events, medical inquiries, and product-related concerns, please call 1-855-336-3322.
Canada: For adverse events, medical inquiries, and product-related concerns, please call 1-877-633-3987.
USA: For Adverse events, medical inquiries, and product related concerns with Rasuvo, please call 1-855-336-3322. Rasuvo : 1-855-336-3322